Product
Supplier
Encyclopedia
Inquiry
AR 50mg 100mg buy - large image1
AR 50mg 100mg buy - image1
AR 50mg 100mg buy - image2

AR 50mg 100mg

Unit Price: Get Latest Price
CAS No.:

761425-93-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

深圳

Packaging:

50mg/vial, 10vials/box

Price valid (until):

2026-08-24

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide

  • Product Description

  • Seller Information

  • Description


      Product Detail  


    1. Ultra-High Purity
    Each batch is synthesized and purified to >99% purity (HPLC), ensuring reliable and reproducible results in sensitive experiments.


    2.Accurate Dosing & Consistency
    Our peptides are precisely weighed and vacuum-sealed under sterile conditions. Batch-to-batch consistency is rigorously maintained.


    3.Endotoxin-Free & Sterile Processing
    Manufactured in a cleanroom environment, our peptides are free from endotoxins, microbial contamination, and other impurities that could interfere with cell-based or in vivo studies.


    Shop ACTH 1-39 5mg-Detailed Image 1  Shop ACTH 1-39 5mg-Detailed Image 3 Shop ACTH 1-39 5mg-Detailed Image 4 Shop ACTH 1-39 5mg-Detailed Image 5 Shop Aicar AR 50mg 100mg-Detailed Image 5

    Items Specifications
    vial mg
    tude g
    bag kg

    Basic Info
    Product Name:

    Clematichinenoside AR

    Other Name:

    Clematichinenoside AR;Olean-12-en-28-oic acid, 3-[(O-6-deoxy-α-L-mannopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-ribopyranosyl-(1→3)-O-6-deoxy-α-L-mannopyranosyl-(1→2)-α-L-arabinopyranosyl)oxy]-, O-6-deoxy-α-L-mannopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl ester, (3β)-;Inhibitor,atherosclerosis,inhibit,Autophagy,arthritis,Clematichinenoside AR;Clematichinenoside AR, 10 mM in DMSO;(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-(((2S,3R,4S,5S)-3-(((2S,3R,4R,5S,6S)-4-(((2S,3R,4S,5R)-5-(((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-3,5-d;Lysocineoside;Clematichinenoside

    CAS No.:

    761425-93-8

    Molecular Formula:

    C82H134O43

    InChIKeys:

    JFLCHMJGYAFQIU-DCYSJDIQNA-N

    Molecular Weight:

    1807.93

    Exact Mass:

    1806.8298829

    Color/Form:

    Off-white to light yellow

    Categories:

    Other Chemical Drugs

    Characteristics
    Density:

    1.58±0.1 g/cm3(Predicted)

    PKA:

    12.50±0.70(Predicted)

    Critical Temperature & Pressure:

    4°C, away from moisture and light

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide

    Location:

    Unit 1207, Elevator 1, Office Tower A2, Wanda Plaza, No. 8 Aojiang Road, Taijiang District, Fuzhou City, Fujian Province

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    1

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2024

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.